Newswise — April 27, 2022 – The combination of radiofrequency (RF) heating and high-intensity focused electromagnetic (HIFEM) energy provides a single, noninvasive procedure for abdominal body shaping – simultaneously reducing belly fat while increasing abdominal muscle mass without surgery, reports a study in the May issue of Plastic and Reconstructive Surgery®, the official medical journal of the American Society of Plastic Surgeons (ASPS).
"Our study, the first randomized trial of the combined RF and HIFEM procedure, documents a significant reduction in abdominal fat with an increase in abdominal muscle thickness," according to the clinical trial report by ASPS Member Surgeon Julene B. Samuels, MD, Louisville, Ky. "These effects are even greater than achieved with RF and HIFEM alone, and are maintained for up to 6 months after treatment."
Greatest effects on abdominal fat and muscle at 3 months
There is growing interest in the use of nonsurgical approaches to body contouring, including RF and HIFEM. Radiofrequency energy is used to increase the temperature of fatty tissue, leading to heat-induced damage of fat cells. Application of HIFEM triggers supramaximal muscle contractions, leading to muscle strengthening and growth. Used separately, RF energy is effective in reducing abdominal fat while HIFEM is effective in increasing muscle mass.
The new technology (marketed as Emsculpt Neo®) combines these two techniques, allowing RF heating and HIFEM energy to be applied simultaneously. The combined RF and HIEM device has received FDA clearance for noninvasive breakdown of abdominal fat.
Dr. Samuels and colleagues performed a randomized trial to evaluate the effects of the combined procedure. The study included 72 patients, average age 45 years, seeking abdominal body shaping. Patients were randomly assigned to receive RF plus HIFEM (48 patients) or an inactive "sham" procedure (24 patients).
Patients underwent three 30-minute treatments delivered once a week for 3 consecutive weeks. Follow-up visits at 1 month (67 patients), 3 months (56 patients), and 6 months (28 patients) included ultrasound scans to measure changes in the thickness of abdominal fat and muscle (rectus abdominis).
At 1 month, patients undergoing RF plus HIFEM had an average 20.5% decrease in abdominal fat with a 21.5% increase in abdominal muscle thickness. Three-month assessments showed further improvement: a 28.3% decrease in abdominal fat and a 24.2% increase in muscle thickness.
In contrast, the sham treatment group had no change in abdominal fat or muscle thickness. Six-month evaluation in patients receiving RF plus HIFEM showed minor, nonsignificant declines in treatment effect.
Ninety-four percent of patients in the RF plus HIFEM were satisfied with their treatment results (as were 40% of the sham treatment group). Side effects consisted of mild, temporary reddening of the skin and soreness of the abdominal muscles, with no significant complications.
Compared to previous studies of RF and HIFEM performed individually, the combined procedure appears to provide greater effects on abdominal fat and muscle thickness. "Enhanced results in our study are thought to be a direct result of simultaneous use of the two modalities as it has been shown that muscle hypertrophy can be enhanced by both mechanical and heat stimulation," Dr. Samuels and coauthors write. They note that their study cannot rule out an effect of increased exercise: patients may have been more motivated to exercise after seeing the initial results of the combined treatment.
"Active treatment utilizing simultaneous application of RF and HIFEM resulted in a significant increase in rectus abdominis thickness and subcutaneous fat reduction, exceeding previously published results for separate HIFEM and RF treatments," the researchers conclude. They emphasize the need for further studies, including assessment of the synergistic effects of RF plus HIFEM in combination and more detailed evaluation of patient-rated outcomes.
About Plastic and Reconstructive Surgery
For over 75 years, Plastic and Reconstructive Surgery® (http://www.prsjournal.com/) has been the one consistently excellent reference for every specialist who uses plastic surgery techniques or works in conjunction with a plastic surgeon. The official journal of the American Society of Plastic Surgeons, Plastic and Reconstructive Surgery® brings subscribers up-to-the-minute reports on the latest techniques and follow-up for all areas of plastic and reconstructive surgery, including breast reconstruction, experimental studies, maxillofacial reconstruction, hand and microsurgery, burn repair and cosmetic surgery, as well as news on medico-legal issues.
The American Society of Plastic Surgeons is the largest organization of board-certified plastic surgeons in the world. Representing more than 7,000 physician members, the society is recognized as a leading authority and information source on cosmetic and reconstructive plastic surgery. ASPS comprises more than 94 percent of all board-certified plastic surgeons in the United States. Founded in 1931, the society represents physicians certified by The American Board of Plastic Surgery or The Royal College of Physicians and Surgeons of Canada.
About Wolters Kluwer
Wolters Kluwer (WKL) is a global leader in professional information, software solutions, and services for the clinicians, nurses, accountants, lawyers, and tax, finance, audit, risk, compliance, and regulatory sectors. We help our customers make critical decisions every day by providing expert solutions that combine deep domain knowledge with advanced technology and services.
Wolters Kluwer reported 2020 annual revenues of €4.6 billion. The group serves customers in over 180 countries, maintains operations in over 40 countries, and employs approximately 19,200 people worldwide. The company is headquartered in Alphen aan den Rijn, the Netherlands.
Wolters Kluwer provides trusted clinical technology and evidence-based solutions that engage clinicians, patients, researchers and students in effective decision-making and outcomes across healthcare. We support clinical effectiveness, learning and research, clinical surveillance and compliance, as well as data solutions. For more information about our solutions, visit https://www.wolterskluwer.com/en/health and follow us on LinkedIn and Twitter @WKHealth.